Is a generic version of Rexulti (brexpiprazole) available in 2025?
No generic Rexulti (brexpiprazole) is widely recognized as available for patients in 2025 based on the information provided here. If a generic had been launched, it would typically appear under brexpiprazole at major U.S. pharmacies and in FDA “drug approval”/generic listings, but that confirmation is not included in the provided information.
When do generics usually appear after Rexulti?
Generic timelines depend on patent and exclusivity expirations for the drug substance and for specific formulations, plus any delays from litigation or regulatory review. Without the underlying patent/exclusivity dates for brexpiprazole in the provided information, there’s no reliable way to state an exact “first generic availability” date for 2025.
What to check to confirm whether generic brexpiprazole is on the market?
To verify quickly, search:
- The pharmacy listing for “brexpiprazole” (not “Rexulti”) to see if any non-brand products appear.
- FDA’s database for approved generics tied to Rexulti’s active ingredient (brexpiprazole).
- The drug’s label history or approval history pages for any generic approvals.
What if you need a cheaper option right now?
If a generic is not available, options patients and clinicians often use include:
- Checking whether insurance covers Rexulti with a lower copay tier.
- Using patient assistance programs (if available) from the brand manufacturer.
- Asking the prescriber about therapeutically appropriate alternatives in the same class (choice depends on diagnosis and prior response).
Can a “generic” exist even if it’s not on shelves yet?
Sometimes an FDA-approved generic exists but may not be widely distributed immediately, or it may launch under a limited number of strengths first. That’s why checking both FDA approval status and real pharmacy availability matters.
Sources
No sources were provided with your question, so none can be cited.